Cleared Traditional

K101075 - ELECSYS INSULIN CALCHECK 5

K101075 is the FDA 510(k) clearance for ELECSYS INSULIN CALCHECK 5 by Roche Diagnostics Corp.. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 53-day FDA review.

K101075 · Roche Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2010
Decision
53d
Days
Class 1
Risk

K101075 is an FDA 510(k) clearance for the ELECSYS INSULIN CALCHECK 5. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on June 11, 2010 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Roche Diagnostics Corp. devices

Submission Details

510(k) Number K101075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2010
Decision Date June 11, 2010
Days to Decision 53 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 88d · This submission: 53d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 268
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K101075.
ELECSYS FERRITIN CALCHECK 5
K102267 · Roche Diagnostics · Sep 2010
ELECSYS DIGOXIN CALCHECK 5
K102044 · Roche Diagnostics · Aug 2010
FORA CONTROL SOLUTION, TAIDOC CONTROL SOLUTION
K093724 · Taidoc Technology Corporation · Jul 2010
ELECSYS FOLATE III CALCHECK 5
K094031 · Roche Diagnostics · Apr 2010
ELECSYS C-PEPTIDE CALCHECK 5
K100810 · Roche Diagnostics · Apr 2010
ELECSYS TSH CALCHECK 5
K093836 · Roche Diagnostics · Apr 2010